Nuvectis Pharma, Inc. Common Stock
Symbol: NVCT (NASDAQ)
6.51
▲ (3.66%) 0.230
Company Description:
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
Key Stats
- Today's Open: $6.31
- Today's High: $6.58
- Today's Low: $6.302
- Today's Volume: 83.25K
- Yesterday Close: $6.28
- Yesterday High: $6.53
- Yesterday Low: $6.27
- Yesterday Volume: 74.14K
- Last Min Volume: 10
- Last Min High: $6.51
- Last Min Low: $6.51
- Last Min VWAP: $6.51
Company Profile
- Name: Nuvectis Pharma, Inc. Common Stock
- Website: https://www.nuvectis.com
- Listed Date: 2022-02-04
- Location: FORT LEE, NJ
- Market Status: Active
- CIK Number: 0001875558
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $159.87M
- Round Lot: 100
- Outstanding Shares: 25.46M
- Asset Type: CS
RECENT FILINGS FOR NVCT
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-05 | 10-Q | View |
| 2025-08-05 | 8-K | View |
| 2025-06-24 | 4 | View |
| 2025-06-20 | 4 | View |
| 2025-06-13 | 8-K | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-05-13 | 4 | View |
| 2025-05-12 | 4/A | View |
| 2025-05-09 | 4 | View |
| 2025-05-09 | 8-K | View |
| 2025-05-09 | 424B5 | View |
| 2025-05-06 | 10-Q | View |
| 2025-05-06 | 8-K | View |
| 2025-04-28 | DEFA14A | View |
| 2025-04-28 | DEF 14A | View |
| 2025-02-25 | 10-K | View |
| 2025-02-25 | 8-K | View |
| 2025-02-11 | 4 | View |
Latest News on NVCT